Procedures for Evaluating Appearance Issues and Granting Authorizations for Participation in FDA Advisory Committees: Draft Guidance for the Public, FDA Advisory Committee Members, and FDA Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 29, 2016
October 1, 2024
a156c1c0-e485-411d-bff1-cdd2ee684bde
Related Documents
Postapproval Methods to Capture Safety and Efficacy Data for Cell and Gene Therapy Products: Draft Guidance for Industry
Guidance DocumentSeptember 24, 2025Center for Biologics Evaluation and Research
Recommendations for the Development of Blood Collection, Processing, and Storage Systems for the Manufacture of Blood Components Using the Buffy Coat Method
Guidance DocumentOctober 17, 2024Center for Biologics Evaluation and Research
Safety Testing of Human Allogeneic Cells Expanded for Use in Cell-Based Medical Products
Guidance DocumentApril 29, 2024Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.